Leo Kirkovsky

426 citations
13 papers · 388 · h-index 12

Impact in

Papers in

Co-authors
Laurie A. LeBrun (3 shared papers)Stephen E. Webber (3 shared papers)Yuefen Zhou (3 shared papers)Charles R. Kissinger (3 shared papers)Amit M. Shah (3 shared papers)Maria V. Sergeeva (3 shared papers)Richard E. Showalter (3 shared papers)Rupal A. Patel (3 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (11 papers)Bioanalysis (2 papers)
Partner nations
United States

In The Last Decade

Leo Kirkovsky

13 papers receiving 314 citations

Peers

Leo Kirkovsky
Comparison fields: 5 of 37
  • Hepatology 172
  • Infectious Diseases 130
  • Organic Chemistry 130
  • Computational Theory and Mathematics 71
  • Immunology 80
Replace Yueheng Jiang with:
Yueheng Jiang United States
Anne Ekker United States
Timothy A. Stammers Canada
Oleg Selyutin United States
Shintaro Hirashima Japan
Sony Agrawal United States
Tim R. Middleton United States
John P. Maxwell United States
Tse‐I Lin Belgium
Maosheng Duan United States
Leo Kirkovsky relative to Yueheng Jiang United States Yueheng Jiang's profile →
Citations per field
00.5×1.6×
Yueheng Jiang · 1×
Citations per year

Countries citing papers authored by Leo Kirkovsky

Since Specialization
Citations

This map shows the geographic impact of Leo Kirkovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Kirkovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Kirkovsky more than expected).

Fields of papers citing papers by Leo Kirkovsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Kirkovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Kirkovsky. The network helps show where Leo Kirkovsky may publish in the future.

Co-authors

The 24 scholars most cited alongside Leo Kirkovsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leo Kirkovsky Line = papers co-authored together Leo Kirkovsky links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)
Bioanalysis ·Brad Ackermann, Hendrik Neubert, Nicola C. Hughes, Fabio Garofolo, Lee Abberley, Stephen C. Alley, Patricia Brown‐Augsburger, Mark Thomas Bustard
201550
2
2014 White Paper on Recent Issues in Bioanalysis: A Full Immersion in Bioanalysis (Part 2 – Hybrid LBA/LCMS, ELN & Regulatory Agencies’ Input)
Bioanalysis ·Dawn R. Dufield, Hendrik Neubert, Fabio Garofolo, Leo Kirkovsky, Lauren F. Stevenson, Isabelle J. Dumont, Surinder Kaur, Keyang Xu
201447
3
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam, Douglas E. Murphy, Chinh V. Tran, Lian‐Sheng Li, Jingjing Zhao, Peter S. Dragovich, Helen Marie McGuire, Alan X. Xiang
200942
4
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine
Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou, Stephen E. Webber, Douglas E. Murphy, Lian‐Sheng Li, Peter S. Dragovich, Chinh V. Tran, Zhongxiang Sun, Frank Ruebsam
200838
5
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam, Stephen E. Webber, Martin T. Tran, Chinh V. Tran, Douglas E. Murphy, Jingjing Zhao, Peter S. Dragovich, Sun Hee Kim
200836
6
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7′-substituents and initial pharmacokinetic assessments
Bioorganic & Medicinal Chemistry Letters ·Lian‐Sheng Li, Yuefen Zhou, Douglas E. Murphy, Nebojsa S. Stankovic, Jingjing Zhao, Peter S. Dragovich, Thomas M. Bertolini, Zhongxiang Sun
200831
7
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·Sun Hee Kim, Martin T. Tran, Frank Ruebsam, Alan X. Xiang, Benjamin K. Ayida, Helen Marie McGuire, David Ellis, Julie K. Blazel
200828
8
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam, Chinh V. Tran, Lian‐Sheng Li, Sun Hee Kim, Alan X. Xiang, Yuefen Zhou, Julie K. Blazel, Zhongxiang Sun
200825
9
4-(1,1-Dioxo-1,4-dihydro-1λ6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·David Ellis, Julie K. Blazel, Stephen E. Webber, Chinh V. Tran, Peter S. Dragovich, Zhongxiang Sun, Frank Ruebsam, Helen Marie McGuire
200823
10
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents
Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Julie K. Blazel, David A. Ellis, Qing Han, Ruhi Kamran, Charles R. Kissinger, Laurie A. LeBrun, Lian‐Sheng Li
200822
11
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties
Bioorganic & Medicinal Chemistry Letters ·Maria V. Sergeeva, Yuefen Zhou, Darian M. Bartkowski, Thomas G. Nolan, Daniel A. Norris, Ellen Okamoto, Leo Kirkovsky, Ruhi Kamran
200820
12
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam, Zhongxiang Sun, Benjamin K. Ayida, Stephen E. Webber, Yuefen Zhou, Qiang Zhao, Charles R. Kissinger, Richard E. Showalter
200815
13
5,5′- and 6,6′-Dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters ·David Ellis, Julie K. Blazel, Chinh V. Tran, Frank Ruebsam, Douglas E. Murphy, Lian‐Sheng Li, Jingjing Zhao, Yuefen Zhou
200911

About Leo Kirkovsky

Leo Kirkovsky is a scholar working on Hepatology, Infectious Diseases, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 13 papers that have together received 388 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (10 papers), Quinazolinone synthesis and applications (7 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Protein purification and stability (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper) and Advanced Biosensing Techniques and Applications (1 paper). The work is most often cited by research in Hepatology (172 citations), Infectious Diseases (130 citations), Organic Chemistry (130 citations), Computational Theory and Mathematics (71 citations) and Immunology (80 citations). Leo Kirkovsky has collaborated with scholars based in United States. Frequent co-authors include Laurie A. LeBrun, Stephen E. Webber, Yuefen Zhou, Charles R. Kissinger, Amit M. Shah, Maria V. Sergeeva, Richard E. Showalter, Rupal A. Patel, Frank Ruebsam and Zhongxiang Sun. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters and Bioanalysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueheng JiangBreakdown of academic impact, for papers by Anne EkkerBreakdown of academic impact, for papers by Timothy A. StammersBreakdown of academic impact, for papers by Oleg SelyutinBreakdown of academic impact, for papers by Shintaro HirashimaBreakdown of academic impact, for papers by Sony AgrawalBreakdown of academic impact, for papers by Tim R. MiddletonBreakdown of academic impact, for papers by John P. MaxwellBreakdown of academic impact, for papers by Tse‐I LinBreakdown of academic impact, for papers by Maosheng Duan